- Home
- GTN vs LAB Comparison
GTN vs LAB Comparison
Compare GTN & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTN
- LAB
- Stock Information
- Founded
- GTN 1897
- LAB 1999
- Country
- GTN United States
- LAB United States
- Employees
- GTN N/A
- LAB N/A
- Industry
- GTN Broadcasting
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- GTN Industrials
- LAB Industrials
- Exchange
- GTN Nasdaq
- LAB Nasdaq
- Market Cap
- GTN 474.7M
- LAB 449.9M
- IPO Year
- GTN N/A
- LAB 2011
- Fundamental
- Price
- GTN $4.46
- LAB $1.40
- Analyst Decision
- GTN Strong Buy
- LAB Hold
- Analyst Count
- GTN 5
- LAB 2
- Target Price
- GTN $7.60
- LAB $1.35
- AVG Volume (30 Days)
- GTN 1.2M
- LAB 1.7M
- Earning Date
- GTN 11-07-2025
- LAB 11-04-2025
- Dividend Yield
- GTN 6.90%
- LAB N/A
- EPS Growth
- GTN N/A
- LAB N/A
- EPS
- GTN 0.43
- LAB N/A
- Revenue
- GTN $3,348,000,000.00
- LAB $169,737,000.00
- Revenue This Year
- GTN N/A
- LAB N/A
- Revenue Next Year
- GTN $13.18
- LAB N/A
- P/E Ratio
- GTN $10.79
- LAB N/A
- Revenue Growth
- GTN N/A
- LAB 79.77
- 52 Week Low
- GTN $2.91
- LAB $0.92
- 52 Week High
- GTN $6.31
- LAB $2.25
- Technical
- Relative Strength Index (RSI)
- GTN 40.09
- LAB 64.73
- Support Level
- GTN $4.55
- LAB $1.16
- Resistance Level
- GTN $5.25
- LAB $1.26
- Average True Range (ATR)
- GTN 0.30
- LAB 0.07
- MACD
- GTN -0.01
- LAB 0.03
- Stochastic Oscillator
- GTN 19.00
- LAB 97.10
About GTN Gray Television Inc.
Gray Media Inc is a multimedia company. The company owns and operates local television stations and digital assets. It also owns Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with digital products and services. Its additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.